ITGA5 as a Dual Regulator of Epithelial‐Mesenchymal Transition and Epithelial Cell Anoikis Resistance: Functional Validation and Drug Prediction
Cell Proliferation · 2026
DOI: 10.1111/cpr.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Ting Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Epithelial Cells, Anoikis, Asthma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, "Jie bang gua shuai" Special Program for Postgraduate Innovative Ability Enhancement of the First Clinical Medical College.
Abstract (Originalsprache)
Airway remodelling is a major contributor to persistent airflow limitation and irreversible lung function impairment in asthma, with epithelial‐mesenchymal transition (EMT) serving as a key driver. However, the molecular mechanisms controlling EMT in asthma epithelium remain incompletely elucidated. This study reported that integrin α5 (ITGA5) was markedly upregulated in asthma patients, house dust mite (HDM)‐sensitised asthma mice, and transforming growth factor beta 1 (TGF‐ β 1)‐induced in vitro EMT models. Elevated ITGA5 expression correlated positively with reduced lung function, asthma severity and higher levels of EMT regulators (Fibronectin, N‐cadherin, Vimentin) and was functionally linked to anoikis resistance. In TGF‐ β 1‐induced bronchial epithelial cells exhibiting anoikis resistance, quantitative proteomics revealed that ITGA5 promoted mesenchymal transition via the phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt) pathway and negatively regulated anoikis. ITGA5 directly bound to PI3K in vitro, and ITGA5 knockdown reversed TGF‐ β 1‐induced EMT, inhibited the activation of the PI3K/Akt pro‐survival pathway, and restored anoikis sensitivity. According to molecular docking, molecular dynamics simulation and in vivo and in vitro pharmacological assays, resveratrol (Res) and M200 were found to be potential ITGA5 inhibitors that successfully reduced EMT and anoikis resistance, thereby attenuating airway remodelling in asthma mice and offering promising drug candidates for ITGA5‐targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Engineering Technology Research Center of Commercialization of Lingnan Special Medical Institution Preparations, Guangzhou, China.
- Lingnan Medical Research Centre of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China.
- Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China.
- Guangdong Engineering Research Center of Comercialization of Medical Institution Preparations and Traditional Chinese Medicines, Guangzhou, China.
ORCID-Profile: Miaofen Zhang, Qiong Liu, Xiufang Huang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- "Jie bang gua shuai" Special Program for Postgraduate Innovative Ability Enhancement of the First Clinical Medical College
- Chinese Association of Chinese Medicine (CACM) Young Talent Support Program
- "Guben" Project for First-Class Discipline Capacity Improvement of Guangzhou University of Chinese Medicine
- Sanming Project of Medicine in Shenzhen
- National Chinese Medicine Advantageous Specialty Construction Project (Pulmonary Disease Department of the First Affiliated Hospital of Guangzhou University of…
- Seventh Batch of "Guangdong Special Support Program" Provincial Health and Health Commission (Health and Health Talents) Project
Zitieren
APA
Wang, T., Rao, L., Li, X., Zhang, M., Huang, H., Luo, Z., Liao, G., Jiang, Y., Zhan, S., Liu, Q., & Huang, X. (2026). ITGA5 as a Dual Regulator of Epithelial‐Mesenchymal Transition and Epithelial Cell Anoikis Resistance: Functional Validation and Drug Prediction. Cell Proliferation. https://doi.org/10.1111/cpr.70190
Vancouver
Wang T, Rao L, Li X, Zhang M, Huang H, Luo Z, et al. ITGA5 as a Dual Regulator of Epithelial‐Mesenchymal Transition and Epithelial Cell Anoikis Resistance: Functional Validation and Drug Prediction. Cell Proliferation. 2026. doi:10.1111/cpr.70190
BibTeX
@article{Wang2026,
author = {Wang, Ting and Rao, Ling and Li, Xiaofang and Zhang, Miaofen and Huang, Huiting and Luo, Zhiyan and Liao, Gang and Jiang, Yong and Zhan, Shaofeng and Liu, Qiong and Huang, Xiufang},
title = {ITGA5 as a Dual Regulator of Epithelial‐Mesenchymal Transition and Epithelial Cell Anoikis Resistance: Functional Validation and Drug Prediction},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70190}
}
EUVIMED